Skip to main content
Michael Schuster, MD, Oncology, New York, NY

MichaelWSchusterMD

Oncology New York, NY

Hematologic Oncology

Professor of Hematology & Oncology, SUNY Stony Brook

Dr. Schuster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schuster's full profile

Already have an account?

  • Office

    520 E 70th St
    # Starr
    New York, NY 10021
    Phone+1 212-746-2119
    Fax+1 212-746-3305

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1987
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1983
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - Present
  • MA State Medical License
    MA State Medical License 1982 - 2025
  • NY State Medical License
    NY State Medical License 1987 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Newsday - Top Doctors on Long Island Castle Connolly, 2011-2020
  • America's Top Doctors for Cancer Castle Connolly, 2005-2020
  • Top Doctors: New York Metro Area Castle Connolly, 2003-2014, 2016-2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Mye...
    Michael W. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid LeukemiaClinically Relevant Abstract
    Michael W. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Professional Memberships